Daiichi Sankyo | Daiichi Sankyo News | Daiichi Sankyo Photos

Web Sify

Sify.com » Topics » Daiichi Sankyo

Daiichi Sankyo News

UPDATE 2-Ranbaxy gets U.S. OK for acne treatment
* Ranbaxy sees U.S. launch of Absorica in Q4 * Cipher, Galephar Pharma to get $9 mln milestone fee * Cipher to draw royalty on sales from Ranbaxy * Cipher shares jump 58 pct to a 4-year high on TSX May 28 (Reuters) - Indian group Ranbaxy Laboratories has received U.S. approval for acne treatment drug Absorica and expects a U.S. launch in the fourth quarter of this year. Ranbaxy holds

Ranbaxy gets U.S. OK for acne treatment

Ranbaxy Laboratories has received U.S. approval for acne treatment drug Absorica and expects a U.S. launch in the fourth quarter of this year. The product was jointly developed by Canadian group

more

Ranbaxy Q1 profit jumps on generic Lipitor

Ranbaxy Laboratories, India's top drugmaker by sales, reported a four-fold rise in quarterly net profit, helped by sales of its generic version of cholesterol drug Lipitor in its key U.S. market,

more

Ranbaxy Q1 profit jumps on generic Lipitor

Ranbaxy Laboratories, India's top drugmaker by sales, reported a four-fold rise in quarterly net profit, helped by sales of its generic version of cholesterol drug Lipitor in its key U.S. market,

more

Ranbaxy's finest hour

The launch by Ranbaxy last week of Synriam, a new drug to treat malaria, is an important milestone. Having made its name by manufacturing generic (off patent) drugs cheaply, India’s

more

Ranbaxy launches malaria drug Synriam
Ranbaxy Laboratories, India's top drugmaker by sales, said it launched a new malaria treatment drug Synriam in the country and was working to introduce it in other Asian countries, Africa and South

more

Daiichi Sankyo Galleries

Was Malvinder forced to quit R...

Daiichi Sankyo Videos

Ranbaxy CEO quits owing to dif...
Ranbaxy CEO quits owing to differences with parent company

1 2 3 4 5 6 7 8 9 10 Next »